Kiwi Not posted in a good while - needed the break Amarin board collectively have failed over many years in to many ways to list but most recently to act expeditiously to stem appallingly wasteful cash burn - they knew income was dropping like a stone in the last quarter but failed to act until after appalling results announced - they then sacked the FD and cut 100million as to cost -much later than they could and should have done The present board don’t want a BO - they want to carry on as they are and make big bucks on the way Denner /Sarrisa as shareholders - they want a profit and a return on the investment in the relatively short term - 2 years at best Clear the board and Denner are diametrically opposed and this is a war between entrenched enriched board members with no real concept of shareholder value and return - and a large shareholder / supported by probably the vast majority of retail and investor shareholders who see the present board as bankrupt as to their management off this business
I agree with your take on this - I do not see this present board as capable of positioning the company over the next two years into a better place for BO - or indeed their even wanting it
Let’s be clear -it’s a dumb notion that it could not be bought tomorrow - iThe company could be bought tomorrow- it’s a question of how much ?? The reality is that the present board either have not put up a for sale sign at all - or have a completely unrealistic price tag for the company that no big pharma will consider paying Alm